U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
February 28, 2015 at 00:38 AM EST
MUMBAI, Feb 28 (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed.